Echosens, FibroScan, non-invasive, liver, VCTE, fibrosis, steatosis
Echosens is a high-tech company providing a full range of devices and solutions for health professionals to assess, diagnose and manage chronic liver disease everywhere, for simpler, faster and better patient care and liver health. Echosens develops, manufactures and markets the FibroScan®, FibroMeter ™ and FibroScan Connect ™ product lines. The ECHOSENS subsidiary located in Shenzhen support ECHOSENS group to gain a better penetration of the Chinese market with a range of local made FibroScan products, as well as through supply-chain synergies. “Because liver health matters”
FibroScan® is a specialized medical equipment that used the Vibration-controlled transient elastography (VCTE®) technology to measure specific biomarkers: liver stiffness measurement (LSM) and controlled attenuation parameter (CAP) which are non-invasive assessments of hepatic fibrosis and steatosis respectively. FibroScan® is recognized worldwide as the reference for liver assessment with more than 2,500+ peer-reviewed publications and 70+ international guidelines. Echosens has made FibroScan® available in over 100+ countries enabling millions of liver examinations worldwide.
